Anti-COVID Monoclonal Cocktails
Newly created treatments for high-risk COVID-19 patients have proved highly effective. Unfortunately, challenges with their distribution and administration have limited their use.
Multisystem Inflammatory Syndrome in Children: A Complication of COVID-19
Much remains to be learned about this new condition affecting a growing number of children. However, it is hoped with increased vaccination and fewer cases of the SARS-CoV-2 virus, case numbers of MIS-C will also go down.
Against the Storm: High-Dose IVIG as an Immunoregulatory Treatment Strategy for Severe COVID-19
While there may be no “magic bullet” to treat cytokine storm, one widely used immunomodulatory agent in particular — polyclonal intravenous immune globulin (IVIG) purified from healthy donor plasma — is distinguished by the simple fact that it is anything but a narrowly targeted treatment.
COVID-19 Vaccines: Where Are We Now?
With three vaccines in circulation and three more on the horizon, is the end of the COVID-19 pandemic in sight?
Long-Term Effects of COVID-19
Long-haul COVID, now termed PASC, is a very real effect of the SARs-CoV-2 virus, but few physicians are familiar with the symptoms and where to send patients for treatment.
Enduring a Persistent Pandemic and Preparing for the Next
It’s almost a year since the pandemic first began ravaging the U.S., leaving healthcare providers grappling with how to care for the millions of Americans who have contracted the coronavirus. Still, scientists do not fully understand how to prevent or treat It.
Pandemic Preparedness: Ensuring the U.S. Is Ready for the Next One?
After several federal agencies spent two decades and tens of billions of dollars preparing for the next pandemic, critics were not shy about pointing out how unprepared the United States was for the current SARS-Cov-2 pandemic.
The Promise of COVID-19 Hyperimmune Immune Globulin Therapy
As of this writing, NIAID and industry collaborators are also finalizing the design of a large-scale trial to assess whether COVID-Ig can reduce the rate of hospitalization and other medical encounters in earlier-stage COVID-19 patients exhibiting mild to moderate symptoms.
Low Serum Albumin Level Strongly Associated with Severe COVID-19
University of Toledo investigators conducted a systematic review and meta-analysis to determine whether there may be an association between hypoalbuminemia and severe COVID-19.
Plasma Therapies: Effective COVID-19 Treatments?
Studies shed light on whether high-dose intravenous immune globulin, convalescent plasma and hyperimmune globulin will be effective therapeutic options for the novel coronavirus.